Mahler DA - Search Results

1

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.

Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, Anzueto A, Halpin DMG, Price DB, Drescher GS, Hoy HM, Haughney J, Hess MW, Usmani OS. Ohar JA, et al. Among authors: mahler da. Int J Chron Obstruct Pulmon Dis. 2022 Jan 6;17:79-92. doi: 10.2147/COPD.S319511. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35023914 Free PMC article. Review.

2

The effect of inhaled beta2-agonists on clinical outcomes in chronic obstructive pulmonary disease.

Mahler DA. Mahler DA. J Allergy Clin Immunol. 2002 Dec;110(6 Suppl):S298-303. doi: 10.1067/mai.2002.129703. J Allergy Clin Immunol. 2002. PMID: 12464939 Review.

3

Diagnosis of chronic obstructive pulmonary disease and differentiation from asthma.

Scott JA, Mahler DA. Scott JA, et al. Among authors: mahler da. Curr Opin Pulm Med. 1995 Mar;1(2):144-9. Curr Opin Pulm Med. 1995. PMID: 15786604 Review.

4

Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease.

Mahler DA. Mahler DA. Proc Am Thorac Soc. 2006 May;3(3):234-8. doi: 10.1513/pats.200509-103SF. Proc Am Thorac Soc. 2006. PMID: 16636091 Review.

5

Assessment tools for chronic obstructive pulmonary disease: do newer metrics allow for disease modification?

Mahler DA, Criner GJ. Mahler DA, et al. Proc Am Thorac Soc. 2007 Oct 1;4(7):507-11. doi: 10.1513/pats.200701-013FM. Proc Am Thorac Soc. 2007. PMID: 17878462 Review.

6

It's about time--directing our attention toward modifying the course of COPD.

Cazzola M, Hanania NA, Jones PW, Mahler DA, Make B, Ohar J, Rennard S. Cazzola M, et al. Among authors: mahler da. Respir Med. 2008 Jun;102 Suppl 1:S37-48. doi: 10.1016/S0954-6111(08)70006-4. Respir Med. 2008. PMID: 18582796 Free article. Review.

7

Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease.

Pillai SG, Kong X, Edwards LD, Cho MH, Anderson WH, Coxson HO, Lomas DA, Silverman EK; ECLIPSE and ICGN Investigators. Pillai SG, et al. Am J Respir Crit Care Med. 2010 Dec 15;182(12):1498-505. doi: 10.1164/rccm.201002-0151OC. Epub 2010 Jul 23. Am J Respir Crit Care Med. 2010. PMID: 20656943 Free PMC article.

8

Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Hurst JR, et al. N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883. N Engl J Med. 2010. PMID: 20843247 Free article.

9

Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD.

Hareendran A, Leidy NK, Monz BU, Winnette R, Becker K, Mahler DA. Hareendran A, et al. Among authors: mahler da. Int J Chron Obstruct Pulmon Dis. 2012;7:345-55. doi: 10.2147/COPD.S29571. Epub 2012 May 28. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 22745534 Free PMC article.

10

Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler.

Mahler DA, Waterman LA, Gifford AH. Mahler DA, et al. J Aerosol Med Pulm Drug Deliv. 2013 Jun;26(3):174-9. doi: 10.1089/jamp.2012.0987. Epub 2012 Oct 1. J Aerosol Med Pulm Drug Deliv. 2013. PMID: 23025451 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page